Search Results - "Lasch, S. J."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates by Trail, P. A., Willner, D., Lasch, S. J., Henderson, A. J., Hofstead, S., Casazza, A. M., Firestone, R. A., Hellström, I., Hellström, K. E.

    “…Immunoconjugates (BR96-DOX) were prepared between chimeric monoclonal antibody BR96 and the anticancer drug doxorubicin. The monoclonal antibody binds an…”
    Get full text
    Journal Article
  2. 2

    (6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicin by Willner, David, Trail, Pamela A, Hofstead, Sandra J, King, H. Dalton, Lasch, Shirley J, Braslawsky, Gary R, Greenfield, Robert S, Kaneko, Takushi, Firestone, Raymond A

    Published in Bioconjugate chemistry (01-11-1993)
    “…The (6-maleimidocaproyl)hydrazone of doxorubicin was synthesized and conjugated to several mAbs, including chimeric BR96, via a Michael addition reaction to…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Synthesis and antitumor activity of the immunoconjugate BR96-Dox by Firestone, R.A., Willner, D., Hofstead, S.J., King, H.D., Kaneko, T., Braslawsky, G.R., Greenfield, R.S., Trail, P.A., Lasch, S.J., Henderson, A.J., Casazza, A.M., Hellström, I., Hellström, K.E.

    Published in Journal of controlled release (01-05-1996)
    “…BR96-Dox is an immunoconjugate (IC) in which doxorubicin (8 equivalents) is linked via an acid-labile hydrazone to the chimeric MAb BR96. It binds to a…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Linkers:  A Novel Method for Increasing the Potency of Doxorubicin Immunoconjugates by King, H. Dalton, Yurgaitis, Derek, Willner, David, Firestone, Raymond A, Yang, Michael B, Lasch, Shirley J, Hellström, Karl Erik, Trail, Pamela A

    Published in Bioconjugate chemistry (01-03-1999)
    “…Immunoconjugates of monoclonal antibody BR96 and Doxorubicin have been prepared using a novel series of branched hydrazone linkers. Since each linker bound to…”
    Get full text
    Journal Article
  6. 6

    Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models by TRAIL, P. A, WILLNER, D, LASCH, S. J, HENDERSON, A. J, GREENFIELD, R. S, KING, D, ZOECKLER, M. E, BRASLAWSKY, G. R

    Published in Cancer research (Chicago, Ill.) (15-10-1992)
    “…The anticarcinoma antibody BR64 was conjugated to a doxorubicin derivative, doxorubicin 13-[3-(2-pyridyldithio)propionyl]hydrazone, and the resulting…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Peptide Linkers:  Inhibition of Aggregation by Methoxytriethyleneglycol Chains by King, H. Dalton, Dubowchik, Gene M, Mastalerz, Harold, Willner, David, Hofstead, Sandra J, Firestone, Raymond A, Lasch, Shirley J, Trail, Pamela A

    Published in Journal of medicinal chemistry (12-09-2002)
    “…High mole ratio BR96 immunoconjugates were synthesized using branched peptide−doxorubicin linkers designed to liberate doxorubicin following antigen-specific…”
    Get full text
    Journal Article
  9. 9

    Doxorubicin immunoconjugates containing bivalent, lysosomally-Cleavable dipeptide linkages by Dubowchik, Gene M, Radia, Shilpa, Mastalerz, Harold, Walker, Michael A, Firestone, Raymond A, Dalton King, H, Hofstead, Sandra J, Willner, David, Lasch, Shirley J, Trail, Pamela A

    Published in Bioorganic & medicinal chemistry letters (03-06-2002)
    “…Bivalent doxorubicin (DOX)-dipeptides ( 16a– c) were prepared and conjugated to the monoclonal antibody BR96. The dipeptides are cleaved by lysosomal proteases…”
    Get full text
    Journal Article
  10. 10

    BR96 conjugates of highly potent anthracyclines by King, H.Dalton, Staab, Andrew J., Pham-Kaplita, Kahnie, Yurgaitis, Derek, Firestone, Raymond A., Lasch, Shirley J., Trail, Pamela A.

    Published in Bioorganic & medicinal chemistry letters (07-07-2003)
    “…The 6-maleimidocaproylhydrazone derivatives of highly potent antitumor agents 5-Diacetoxypentyldoxorubicin and Morpholinodoxorubicin were synthesized and…”
    Get full text
    Journal Article